Correlation Between Caribou Biosciences and Lexaria Bioscience
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Lexaria Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Lexaria Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Lexaria Bioscience Corp, you can compare the effects of market volatilities on Caribou Biosciences and Lexaria Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Lexaria Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Lexaria Bioscience.
Diversification Opportunities for Caribou Biosciences and Lexaria Bioscience
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Caribou and Lexaria is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Lexaria Bioscience Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lexaria Bioscience Corp and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Lexaria Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lexaria Bioscience Corp has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Lexaria Bioscience go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Lexaria Bioscience
Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Lexaria Bioscience. But the stock apears to be less risky and, when comparing its historical volatility, Caribou Biosciences is 1.22 times less risky than Lexaria Bioscience. The stock trades about -0.15 of its potential returns per unit of risk. The Lexaria Bioscience Corp is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 215.00 in Lexaria Bioscience Corp on September 26, 2024 and sell it today you would earn a total of 8.00 from holding Lexaria Bioscience Corp or generate 3.72% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Caribou Biosciences vs. Lexaria Bioscience Corp
Performance |
Timeline |
Caribou Biosciences |
Lexaria Bioscience Corp |
Caribou Biosciences and Lexaria Bioscience Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Caribou Biosciences and Lexaria Bioscience
The main advantage of trading using opposite Caribou Biosciences and Lexaria Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Lexaria Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lexaria Bioscience will offset losses from the drop in Lexaria Bioscience's long position.Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Lexaria Bioscience vs. Fate Therapeutics | Lexaria Bioscience vs. Caribou Biosciences | Lexaria Bioscience vs. Karyopharm Therapeutics | Lexaria Bioscience vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Stocks Directory Find actively traded stocks across global markets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |